• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MINN UNKNOWN_NEUROVASCULAR_PRODUCT; CATHETER, BALLOON TYPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MINN UNKNOWN_NEUROVASCULAR_PRODUCT; CATHETER, BALLOON TYPE Back to Search Results
Catalog Number UNK_NEU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hematoma (1884); Hemorrhage/Bleeding (1888); Inflammation (1932); Perforation (2001); Transient Ischemic Attack (2109); Vasoconstriction (2126); Embolism/Embolus (4438)
Event Date 04/18/2023
Event Type  Death  
Event Description
The survey was conducted in germany, spain and united states.During 28 days follow-up, inflammation of the puncture site (self-resolving), hematoma and hemorrhage at puncture site that prolonged the patient's hospitalization, symptomatic (post-procedural) vasospasm death, post procedural neurological deficit (including tia, stroke) that could be attributed solely to the use of the system's catheter, infection of the puncture site requiring oral or systemic antibiotics, intraprocedural vessel perforation, intraprocedural embolic episode secondary to use of catheter, symptomatic (post-procedural) vasospasm, intraprocedural embolic episode secondary to use of catheter, symptomatic intraprocedural intracranial hemorrhage secondary to use of catheter was reported.No further information was provided.
 
Manufacturer Narrative
H3 other text : the device is not available to the manufacturer.
 
Event Description
The survey was conducted in germany, spain and united states.During 28 days follow-up, inflammation of the puncture site (self-resolving), hematoma and hemorrhage at puncture site that prolonged the patient's hospitalization, symptomatic (post-procedural) vasospasm - death, post procedural neurological deficit (including tia, stroke) that could be attributed solely to the use of the system's catheter, infection of the puncture site requiring oral or systemic antibiotics, intraprocedural vessel perforation, intraprocedural embolic episode secondary to use of catheter, symptomatic (post-procedural) vasospasm, intraprocedural embolic episode secondary to use of catheter, symptomatic intraprocedural intracranial hemorrhage secondary to use of catheter was reported.No further information was provided.
 
Manufacturer Narrative
Although the lot number was not provided, the automated manufacturing execution system (mes) has controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, functional testing as well as visual testing cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.Based upon medical review, the harm observed in this complaint is anticipated in nature as per the device risk assessment.As a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted within the dfu, product labeling and/or risk documentation files, an assignable cause of anticipated procedural complication will be assigned to as reported "patient death, patient hematoma, patient vasospasm serious, patient hemorrhage - blood loss with sequelae, patient inflammation, patient tia(transient ischemic attack), patient stroke, patient vessel perforation, patient infection, patient thromboembolic event".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN_NEUROVASCULAR_PRODUCT
Type of Device
CATHETER, BALLOON TYPE
Manufacturer (Section D)
BOSTON SCIENTIFIC - MINN
one scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC - MINN
one scimed place
maple grove MN 55311
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key16907720
MDR Text Key314971492
Report Number3008853977-2023-00017
Device Sequence Number1
Product Code GBA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H050001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_NEU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Death;
-
-